Prevalence of antiphospholipid antibodies in syrian patients with thrombosis

Iranian Journal of Immunology

Volumn 6, Issue 3, 2009, Pages 154-159

  Deeb, Ali ^a   Hamdoun, Said ^a   Dababo, Khaled ^a  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; SLE

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; CARDIOLIPIN ANTIBODY;

ACUTE HEART INFARCTION; ADULT; ANTIBODY DETECTION; ARTERY THROMBOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETINAL VENOUS THROMBOSIS; RISK ASSESSMENT; RISK FACTOR; SYRIAN ARAB REPUBLIC; THROMBOSIS; VEIN THROMBOSIS; ADOLESCENT; BLOOD; EPIDEMIOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SYRIA; THROMBOSIS; YOUNG ADULT;

EID: 74049132369     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythemato-sus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990;112:682-98.
2. Amigo MC, Khamashta MA. Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am. 2000; 26: 331-48.
3. de Larranaga GF, Forastiero RR, Carreras LO, Alonso BS. Different types of anti- phospholipid antibodies in AIDS: a com-parison with syphilis and the antiphospholipid syndrome. Thromb Res. 1999; 96: 19-25.
4. Ordi-Ros J, Villarreal J, Monegal F, Sauleda S, Esteban I, Vilardell M. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol. 2000;7:241-4.
5. Asherson RA. Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmun. 2000;15: 117-22.
6. Sammaritano L. Drug-induced antiphospholipid antibodies. In: Khamashta MA, ed. Hughes syndrome, antiphospholipid syn-drome. Sprynger., 2000; 144-54.
7. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986;13:486-9.
8. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on prelimi-nary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999; 42: 1309-11.
9. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris E N. Measurement of anti-cardiolipin antibodies by an en-zyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol. 1985; 62: 738-45.
10. Palomo I, Pereira J, Alarcon M, Larrain AM, Pinochet C, Vasquez M, et al. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 2002;140:336-41.
11. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of the Subcommittee on Lupus Anticoagu-lant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Hemost. 1995;74: 1185-90.
12. Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, et al. Antiphospholipid antibodies and venous thromboembolism. Blood. 1995; 86:3685-91.
13. Eschwège V, Peynaud-Debayle E, Wolf M, Amiral J, Vissac AM, Bridey F, et al. Prevalence of antiph- ospholipid-related antibodies in unselected patients with history of venous thrombosis. Blood Coagul Fibrinolysis. 1998; 9:429-34.
14. Lee SS, Cho ML, Joo YS, Kim WU, Hong YS, Min JK, et al. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. J Rheumatol. 2001; 28:520-4.
15. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid anti-bodies: 48 cases. Neurology 1990; 40:1181-9.
16. Cobo-Soriano R, Sánchez-Ramón S, Aparicio MJ, Teijeiro MA, Vidal P, Suárez-Leoz M, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol.1999;128:725-32.
17. Carbone J, Sánchez-Ramón S, Cobo-Soriano R, Seoane E, Aparicio MJ, Ruiz-Tíscar JL, et al. Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases. J Rheumatol. 2001;28:2437-41.
18. Dunn JP, Noorily SW, Petri M, Finkelstein D, Rosenbaum JT, Jabs DA. Antiphospholipid antibodies and retinal vascular disease. Lupus. 1996; 5:313-22.
19. Montehermoso A, Cervera R, Font J, Ramos-Casals M, García-carrasco M, Formiga F, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999; 28:326-32.
20. Shah NM, Khamashta MA, Atsumi T, Hughes GR. Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus. 1998; 7:3-6.
21. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology. 1993; 43:2069-73.
22. Brey RL, Abbott RD, Curb JD, Sharp DS, Ross GW, Stallworth CL, et al. beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the Honolulu heart program. Stroke. 2001;32:1701-6.
23. Levine SR, Brey RL, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrzema B, et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol. 1995;38:119-24.
24. Montalbán J, Rio J, Khamastha M, Davalos A, Codina M, Swana GT, et al. Value of immunologic testing in stroke patients. A prospective multicenter study. Stroke. 1994;25:2412-5.
25. Fiallo P, Tomasina C, Clapasson A, Cardo PP Antibodies to beta(2)-glycoprotein I in ischemic stroke. Cerebrovasc Dis. 2000; 10:293-7.
26. Asherson RA, Cervera R. Cardiac manifestations of the antiphospholipid syndrome. Coron Artery Dis. 1993; 4:1137-43.
27. Phadke KV, Phillips RA, Clarke DT, Jones M, Naish P, Carson P. Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J. 1993; 69:391-4.
28. Gaeta G, Lupoli S, Brancaccio V, Effuso L, Russo V, Boccalatte A. Anticardiolipin antibodies and early infarct of the myo-cardium. Cardiologia 1998; 43:731-5.
29. Sletnes KE, Larsen EW, Stokland O, Wisløff F. Antiphospholipid antibodies detected as anticephalin and anticardiolipin anti-bodies in patients with acute myocardial infarction: immunological response to myocardial necrosis? Thromb Res. 1990;59:675-80.
30. Mattila K, Vaarala O, Palosuo T, Malkamäki M, Valtonen V, Nieminen M, et al. Serologic response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clin Immunol Immunopathol. 1989;51:414-8.